AV

Apoorva Vivek Vaidya

Active Director Designated Partner DIN 11751023
DIN 11751023 First appointment Jun 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Apoorva Vivek Vaidya

Apoorva Vivek Vaidya is a Designated Partner at Sano Healthcare And Tourism Llp (since 2026).

DIN 11751023
Primary Designation Designated Partner
First Appointment 01 Jun 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner01 Jun 20262026Active

Board colleagues of Apoorva Vivek Vaidya

NameDINCompanyDesignation
Medha Shripad Kakade08618408Sano Healthcare And Tourism LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Sano Healthcare And Tourism Llp
Premium access

Shareholding and investment profile for Apoorva Vivek Vaidya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Apoorva Vivek Vaidya

Apoorva Vivek Vaidya currently holds 1 directorship: Sano Healthcare And Tourism Llp (Designated Partner, since 01 Jun 2026).

Apoorva Vivek Vaidya was first appointed on 01 Jun 2026 as Designated Partner at Sano Healthcare And Tourism Llp.

The current boards of Apoorva Vivek Vaidya's companies include Medha Shripad Kakade (Sano Healthcare And Tourism Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available